Riccardo Cappato

Full Professor n.t.
Cardiovascular Diseases

Chief of the Arrhythmia and Electrophysiology Center at Humanitas Research Hospital (Milan)
Director of the Electrophysiology II Unit at Humanitas Gavazzeni (Bergamo)

Email riccardo.cappato@hunimed.eu 
Phone + 39 02 82244005
Site humanitas.net/doctors/cappato-riccardo

Education and Academic Background

Dr. Riccardo Cappato is currently Director of the Arrhythmia and Electrophysiology Research Center at IRCCS Humanitas Research Center in Rozzano (Milan), Italy, and Director of the Arrhythmia and Electrophysiology II Center at Humanitas Gavazzeni Clinics, Bergamo, Italy. He is the current President of the European Cardiac Arrhythmia Society (ECAS). He has also been the Co-Director of the Europe AF Congress, held in London on an annual basis, during the 10 editions since 2007.

Dr. Cappato began his medical training at the University of Ferrara, completing it in 1989. He was a junior physician in the Department of Cardiology of the Arcispedale Santa Anna di Ferrara, Italy, where he also completed his internship and residency. Between 1993 and 2000, he was the Co-Director of the Electrophysiology Laboratory at Eppendorf University and St. Georg General Hospital, Hamburg, Germany. Between 2000 and 2015 he was the Director of the “Clinical Arrhythmia and EP Center” of Policlinico San Donato in Milan.

Scientific and Research Interests

His clinical interests are mainly focused on the following topics:

  1. Management of supraventricular and ventricular arrhythmias, and in their treatment with trans-catheter radiofrequency ablation
  2. New therapy forms for anti-bradycardia and anti-tachycardia pacing
  3. Use of novel oral anticoagulants to prevent thromboembolic events in patients with atrial fibrillation

Dr Cappato is the Principal Investigator for X-VERT and VENTURE-AF studies, two multi-center randomized studies enrolling overall 1,500 and 250 patients worldwide. Dr. Cappato is also the leading investigator of a patient-based worldwide atrial fibrillation ablation survey. He has published over 300 peer-reviewed journals and book chapters. He is reviewer or member of the editorial board of numerous Cardiology and Internal Medicine Journals.

He is the co-inventor of the sub-cutaneous implantable cardioverter defibrillator (S-ICD), a technology currently used for preventing sudden cardiac death in more than 25,000 patients worldwide.

 

Selected publications

  1. Cappato, H. Calkins, S.A. Chen, W. Davies, Y. Iesaka, J. Kalman, Y.H. Kim, G. Klein, D. Packer, A. Skanes. – “Worldwide Survey on the Methods, Efficacy, and Safety of Catheter ablation for Human Atrial Fibrillation”. Circulation. 2005; 111 (9): 1100 – 5.
  2. H. Bardy, W.M. Smith, M.A. Hood, I.G. Crozer, I.C. Melton, L. Jordaens, D. Theuns, R.E. Park, D.J. Wright, D.T. Connelly, S.P. Fynn, F.D Murgatroyd, J. Sperzel, J. Neuzner, S.G. Spitzer, A.V. Ardashev, A. Oduro, L. Boersma, A.H Maas, I.C. Van Gelder, A.A. Wilde, P.F Van Dessel, R.E. Knops, C.S. Barr, P. Lupo, R. Cappato, A.A. Grace. – “An Entirely Subcutaneous Implantable Cardioverter –Defibrillator”. The New England Journal of Medicine 2010;363(1):36-44.
  3. Cappato, S. Negroni, D. Pecora, S. Bentivegna, P. Lupo, A. Carolei, C. Esposito, F. Furlanello, L. De Ambroggi. – “Prospective Assessment of Late Conduction Recurrence Across Radiofrequency Lesions Producing Electrical Disconnection at the Pulmonary Vein Ostium in Patients with Atrial Fibrillation”. Circulation. 2003; 108 (13): 1599-604.
  4. Cappato, M.D. Ezekowitz, A.L. Klein, A.J. Camm, CS. Ma, JY Le Heuzey, M. Talajic, M. Scanavacca, P.E. Vardas, P. Kirchhof, M. Hemmrich, V. Lanius, IL. Meng, P. Wildgoose, M. van Eickels, S.H. Hohnloser on behalf of the X-VeRT Investigators. – “Rivaroxaban vs. Vitamin K antagonist for cardioversion in atrial fibrillation”. European Heart Journal 2014;35:3346-55. 
  1. Cappato R, Marchlinski FE, Hohnloser SH, Naccarelli GV, Xiang J, Wilber DJ, Ma CS, Hess S, Wells DS, Juang G, Vijgen J, Hügl BJ, Balasubramaniam R, De Chillou C, Davies DW, Fields LE, Natale A; – Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. VENTURE-AF Investigators. Eur Heart J. 2015 Jul 21;36(28):1805-11.

 

Academic honors, awards and prizes

  • Premio Nazionale ANMCO, “G. Binda,  Per la Ricerca Scientifica per il Lavoro; “Metodi per Valutare nell’Uomo gli Effetti Diretti e quelli Neuromediati dei Farmaci Antiaritmici”. 27 Aprile 1986.
  • Premio Boehringer Ingelheim Italia, “ L’Attività di Ricerca Scientifica in Campo Cardiologico” 28 Aprile1993.
  • Premio Nazionale L’altra Italia: Vite da Premio IX Edizione. -22 Settembre 2012.
Why
Humanitas
University?
An Established Institution

An Established Institution
Humanitas is a renowned healthcare institution that has offered Medical Degrees for well over a decade as a partner of the University of Milan.

An International Career

An International Career
Join our international medical community where classes are taught in English by experienced professors and medical doctors from around the world. Your degree will allow you to work as a MD in the EU and abroad.

Clinical Experience

Clinical Experience
Direct clinical experience is supported by a solid tutoring system and starts in your third year, which gives you considerable practical experience.

Innovative and Active Teaching

Innovative and Active Teaching
Humanitas curriculum is enhanced by a wide variety of active learning methods based on a student-centred approach (Problem-Based Learning, Case method, Concept maps, Simulated patients).

Milano and Italy

Milano and Italy
Enjoy the style, culture, gastronomy and entertainment of one of Europe's most exciting cities. Venture further to experience the delights of Italy or use the opportunity to learn Italian.

Advanced Research and Technology

Advanced Research and Technology
Humanitas can count on state-of-the-art technologies and research experience. A new simulation centre of 1000 sm, designed according to the highest technological standards, will be ready for autumn 2017.

Contact Us

Contact
Humanitas University
Via Rita Levi Montalcini 4,
Pieve Emanuele 20090 Milan, Italy

To receive our updates subscribe here: Newsletter.

How to Reach Us
From Malpensa Airport

Take the A8 highway, following the signs for Milan. Get on the Tangenziale Ovest (western ring road), exit at Quinto de’ Stampi/Via dei Missaglia (7 bis). Follow the route described in the highway section.

From Linate Airport

Take the A8 highway, following the signs for Milan. Get on the Tangenziale Ovest (western ring road), exit at Quinto de’ Stampi/Via dei Missaglia (7 bis). Follow the route described in the highway section.

From Central station

Take the A8 highway, following the signs for Milan. Get on the Tangenziale Ovest (western ring road), exit at Quinto de’ Stampi/Via dei Missaglia (7 bis). Follow the route described in the highway section.

From the city center

Go straight on from Porta Ticinese, to Corso San Gottardo, to via Meda, via Montegani, and via dei Missaglia, then follow the signs for Istituto Clinico Humanitas, or Basiglio Milano 3.

From the highway

Go straight on from Porta Ticinese, to Corso San Gottardo, to via Meda, via Montegani, and via dei Missaglia, then follow the signs for Istituto Clinico Humanitas, or Basiglio Milano 3.

By public transport

Go straight on from Porta Ticinese, to Corso San Gottardo, to via Meda, via Montegani, and via dei Missaglia, then follow the signs for Istituto Clinico Humanitas, or Basiglio Milano 3.